Hepatitis C virus E2 envelope protein induces dendritic cell maturation

Journal of Viral Hepatitis

Volumn 14, Issue 12, 2007, Pages 849-858

  Zhou, Y ^a   Lukes, Y ^a   Anderson, J ^a   Fileta, B ^a   Reinhardt, B ^a   Sjogren, M ^a  

^a WALTER REED ARMY MEDICAL CENTER   (United States)

Author keywords

Dendritic cell; HCV E2; Hepatitis C; T cell activation

Indexed keywords

B7 ANTIGEN; BOVINE SERUM ALBUMIN; CD83 ANTIGEN; CD86 ANTIGEN; CELL SURFACE MARKER; ENVELOPE PROTEIN; GAMMA INTERFERON; GLYCOPROTEIN E2; GLYCOPROTEIN P 15095; INTERLEUKIN 12; LATEX; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ARTICLE; CELL ACTIVITY; CELL FUNCTION; CELL MATURATION; CELL PROLIFERATION; CONTROLLED STUDY; DENDRITIC CELL; DOSE RESPONSE; ENDOCYTOSIS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; HYPOTHESIS; IMMUNE RESPONSE; PHAGOCYTOSIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TRANSPORT; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

CELL PROLIFERATION; DENDRITIC CELLS; ENDOCYTOSIS; HUMANS; INTERFERON TYPE II; INTERLEUKIN-12; LEUKOCYTES, MONONUCLEAR; PHAGOCYTOSIS; PHENOTYPE; RECOMBINANT PROTEINS; T-LYMPHOCYTES; VIRAL ENVELOPE PROTEINS;

EID: 36749020651     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/j.1365-2893.2007.00879.x     Document Type: Article

References (49)

1. Armstrong GL, Wasley A, Simard EP, McQuillan GM, Kuhnert WL, Alter MJ. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann Intern Med 2006 144 : 705 714.
2. El-Serag HB, Davila JA, Petersen NJ, McGlynn KA. The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update. Ann Intern Med 2003 139 : 817 823.
3. Choo QL, Richman KH, Han JH et al. Genetic organization and diversity of the hepatitis C virus. Proc Natl Acad Sci U S A 1991 88 : 2451 2455.
4. Lindenbach BD, Rice CM, eds. Flaviviridae: The Viruses and Their Replication. Philadelphia, PA : Lippincott Williams & Wikins, 2001 : 991 1041.
5. Voisset C, Dubuisson J. Functional hepatitis C virus envelope glycoproteins. Biol Cell 2004 96 : 413 420.
6. Wack A, Soldaini E, Tseng C, Nuti S, Klimpel G, Abrignani S. Binding of the hepatitis C virus envelope protein E2 to CD81 provides a co-stimulatory signal for human T cells. Eur J Immunol 2001 31 : 166 175.
7. Tseng CT, Klimpel GR. Binding of the hepatitis C virus envelope protein E2 to CD81 inhibits natural killer cell functions. J Exp Med 2002 195 : 43 49.
8. Lyons AB. Analysing cell division in vivo and in vitro using flow cytometric measurement of CFSE dye dilution. J Immunol Methods 2000 243 : 147 154.
9. Cella M, Salio M, Sakakibara Y, Langen H, Julkunen I, Lanzavecchia A. Maturation, activation, and protection of dendritic cells induced by double-stranded RNA. J Exp Med 1999 189 : 821 829.
10. Verdijk RM, Mutis T, Esendam B et al. Polyriboinosinic polyribocytidylic acid [poly(I:C)] induces stable maturation of functionally active human dendritic cells. J Immunol 1999 163 : 57 61.
11. Sallusto F, Cella M, Danieli C, Lanzavecchia A. Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products. J Exp Med 1995 182 : 389 400.
12. Steinman RM, Swanson J. The endocytic activity of dendritic cells. J Exp Med 1995 182 : 283 288.
13. Kim HS, Lee JK, Yang IH et al. Identification of hepatitis C virus core domain inducing suppression of allostimulatory capacity of dendritic cells. Arch Pharm Res 2002 25 : 364 369.
14. Sarobe P, Lasarte JJ, Zabaleta A et al. Hepatitis C virus structural proteins impair dendritic cell maturation and inhibit in vivo induction of cellular immune responses. J Virol 2003 77 : 10862 10871.
15. Siavoshian S, Abraham JD, Thumann C, Kieny MP, Schuster C. Hepatitis C virus core, NS3, NS5A, NS5B proteins induce apoptosis in mature dendritic cells. J Med Virol 2005 75 : 402 411.
16. Dolganiuc A, Kodys K, Kopasz A et al. Hepatitis C virus core and nonstructural protein 3 proteins induce pro- and anti-inflammatory cytokines and inhibit dendritic cell differentiation. J Immunol 2003 170 : 5615 5624.
17. Auffermann-Gretzinger S, Keeffe EB, Levy S. Impaired dendritic cell maturation in patients with chronic, but not resolved, hepatitis C virus infection. Blood 2001 97 : 3171 3176.
18. Anthony DD, Yonkers NL, Post AB et al. Selective impairments in dendritic cell-associated function distinguish hepatitis C virus and HIV infection. J Immunol 2004 172 : 4907 4916.
19. Kanto T, Inoue M, Miyatake H et al. Reduced numbers and impaired ability of myeloid and plasmacytoid dendritic cells to polarize T helper cells in chronic hepatitis C virus infection. J Infect Dis 2004 190 : 1919 1926.
20. Murakami H, Akbar SM, Matsui H, Horiike N, Onji M. Decreased interferon-alpha production and impaired T helper 1 polarization by dendritic cells from patients with chronic hepatitis C. Clin Exp Immunol 2004 137 : 559 565.
21. Wedemeyer H, He XS, Nascimbeni M et al. Impaired effector function of hepatitis C virus-specific CD8+ T cells in chronic hepatitis C virus infection. J Immunol 2002 169 : 3447 3458.
22. Gruener NH, Lechner F, Jung MC et al. Sustained dysfunction of antiviral CD8+ T lymphocytes after infection with hepatitis C virus. J Virol 2001 75 : 5550 5558.
23. Semmo N, Day CL, Ward SM et al. Preferential loss of IL-2-secreting CD4+ T helper cells in chronic HCV infection. Hepatology 2005 41 : 1019 1028.
24. Ulsenheimer A, Gerlach JT, Gruener NH et al. Detection of functionally altered hepatitis C virus-specific CD4 T cells in acute and chronic hepatitis C. Hepatology 2003 37 : 1189 1198.
25. Rosa D, Saletti G, De Gregorio E et al. Activation of naive B lymphocytes via CD81, a pathogenetic mechanism for hepatitis C virus-associated B lymphocyte disorders. Proc Natl Acad Sci U S A 2005 102 : 18544 18549.
26. Zhao LJ, Wang L, Ren H et al. Hepatitis C virus E2 protein promotes human hepatoma cell proliferation through the MAPK/ERK signaling pathway via cellular receptors. Exp Cell Res 2005 305 : 23 32.
27. Mazzocca A, Sciammetta SC, Carloni V et al. Binding of hepatitis C virus envelope protein E2 to CD81 up-regulates matrix metalloproteinase-2 in human hepatic stellate cells. J Biol Chem 2005 280 : 11329 11339.
28. Alter MJ, Kruszon-Moran D, Nainan OV et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med 1999 341 : 556 562.
29. Diepolder HM, Zachoval R, Hoffmann RM, Jung MC, Gerlach T, Pape GR. The role of hepatitis C virus specific CD4+ T lymphocytes in acute and chronic hepatitis C. J Mol Med 1996 74 : 583 588.
30. Pape GR, Gerlach TJ, Diepolder HM, Gruner N, Jung M, Santantonio T. Role of the specific T-cell response for clearance and control of hepatitis C virus. J Viral Hepat 1999 6 (Suppl. 1 36 40.
31. Gruner NH, Gerlach TJ, Jung MC et al. Association of hepatitis C virus-specific CD8+ T cells with viral clearance in acute hepatitis C. J Infect Dis 2000 181 : 1528 1536.
32. Cucchiarini M, Kammer AR, Grabscheid B et al. Vigorous peripheral blood cytotoxic T cell response during the acute phase of hepatitis C virus infection. Cell Immunol 2000 203 : 111 123.
33. Gerlach JT, Diepolder HM, Jung MC et al. Recurrence of hepatitis C virus after loss of virus-specific CD4(+) T-cell response in acute hepatitis C. Gastroenterology 1999 117 : 933 941.
34. Lechner F, Gruener NH, Urbani S et al. CD8+ T lymphocyte responses are induced during acute hepatitis C virus infection but are not sustained. Eur J Immunol 2000 30 : 2479 2487.
35. Goutagny N, Fatmi A, De Ledinghen V et al. Evidence of viral replication in circulating dendritic cells during hepatitis C virus infection. J Infect Dis 2003 187 : 1951 1958.
36. Chan SH, Perussia B, Gupta JW et al. Induction of interferon gamma production by natural killer cell stimulatory factor: characterization of the responder cells and synergy with other inducers. J Exp Med 1991 173 : 869 879.
37. Heufler C, Koch F, Stanzl U et al. Interleukin-12 is produced by dendritic cells and mediates T helper 1 development as well as interferon-gamma production by T helper 1 cells. Eur J Immunol 1996 26 : 659 668.
38. Aberle JH, Formann E, Steindl-Munda P et al. Prospective study of viral clearance and CD4(+) T-cell response in acute hepatitis C primary infection and reinfection. J Clin Virol 2006 36 : 24 31.
39. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998 392 : 245 252.
40. Arrighi JF, Rebsamen M, Rousset F, Kindler V, Hauser C. A critical role for p38 mitogen-activated protein kinase in the maturation of human blood-derived dendritic cells induced by lipopolysaccharide, TNF-alpha, and contact sensitizers. J Immunol 2001 166 : 3837 3845.
41. Hofer S, Rescigno M, Granucci F, Citterio S, Francolini M, Ricciardi-Castagnoli P. Differential activation of NF-kappa B subunits in dendritic cells in response to Gram-negative bacteria and to lipopolysaccharide. Microbes Infect 2001 3 : 259 265.
42. Pileri P, Uematsu Y, Campagnoli S et al. Binding of hepatitis C virus to CD81. Science 1998 282 : 938 941.
43. Scarselli E, Ansuini H, Cerino R et al. The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus. EMBO J 2002 21 : 5017 5025.
44. Lozach PY, Lortat-Jacob H, de Lacroix de Lavalette A et al. DC-SIGN and L-SIGN are high affinity binding receptors for hepatitis C virus glycoprotein E2. J Biol Chem 2003 278 : 20358 20366.
45. Takikawa S, Ishii K, Aizaki H et al. Cell fusion activity of hepatitis C virus envelope proteins. J Virol 2000 74 : 5066 5074.
46. Agnello V, Abel G, Elfahal M, Knight GB, Zhang QX. Hepatitis C virus and other flaviviridae viruses enter cells via low density lipoprotein receptor. Proc Natl Acad Sci U S A 1999 96 : 12766 12771.
47. Geijtenbeek TB, Torensma R, van Vliet SJ et al. Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses. Cell 2000 100 : 575 585.
48. Engering A, Geijtenbeek TB, van Vliet SJ et al. The dendritic cell-specific adhesion receptor DC-SIGN internalizes antigen for presentation to T cells. J Immunol 2002 168 : 2118 2126.
49. Yamada E, Montoya M, Schuettler CG et al. Analysis of the binding of hepatitis C virus genotype 1a and 1b E2 glycoproteins to peripheral blood mononuclear cell subsets. J Gen Virol 2005 86 : 2507 2512.